N O'Connor-Byrne S Glavey R Tudor P Murphy C J Thompson J Quinn
10.1186/s40164-019-0128-y
Exp Hematol Oncol
2019 Feb 1;8:4.
bortezomib hyponatremia multiple myeloma tolvaptan
CC BY
https://pubmed.ncbi.nlm.nih.gov/30733892/
Case Reports
PMC6359864
30733892
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
2019